Nantahala Capital Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Nantahala Capital Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-8,263,335	Closed	-$14M	–	107
2018 Q3	$14M	Sell	8,263,335 -3,315,233	-29%	-$5.93M	0.38%	48
2018 Q2	$20.1M	Hold	11,578,568	–	–	0.82%	35
2018 Q1	$21.2M	Buy	11,578,568 +4,578,568	+65%	+$9.67M	0.96%	28
2017 Q4	$15.6M	Buy	+7,000,000	New	+$17.4M	0.69%	35
2016 Q2	–	Sell	-300,000	Closed	-$828K	–	72
2016 Q1	$828K	Buy	+300,000	New	+$1.09M	0.09%	61
2015 Q2	–	Sell	-142,209	Closed	-$657K	–	77
2015 Q1	$657K	Buy	+142,209	New	+$462K	0.11%	71

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

OCM

Opti Capital Management New York $1.64B AUM 0% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Nantahala Capital Management's SGYP Position: Q4 2018 in Review

Nantahala Capital Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 8,263,335 shares — an estimated $14M sold.

Nantahala Capital Management first reported a position in SGYP in Q1 2015 and held it in 6 quarters. The position peaked at $21.2M in Q1 2018. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

Nantahala Capital Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
Nantahala Capital Management sold 8,263,335 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $14M.
Nantahala Capital Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2015 and held it in 6 quarters.
Nantahala Capital Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $21.2M in Q1 2018.
89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Nantahala Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.